Loading...
XSHG
688580
, Last price  
Name

Nanjing Vishee Medical Technology Co Ltd

Chart & performance

D1W1MN
XSHG:688580 chart
P/E
—
P/S
—
EPS
2.01
Vol. 1Y
—
Shs. 5Y
3.17%
Rev. 5Y
4.11%
Div Yld LY
—
Div Yld TTM
—
Revenues
463m
+15.66%
48,853,15958,160,74580,504,45195,903,788144,495,128207,781,492318,873,165378,367,273430,044,458321,621,418462,223,134400,058,923462,725,700
Net income
138m
+35.41%
13,993,04321,749,23428,127,37223,147,77540,338,25663,364,49599,718,299143,659,351177,811,88893,825,899136,258,635101,969,232138,072,645
CFO
177m
+49.42%
8,226,68415,006,38925,218,16130,980,90552,349,51585,844,946141,472,081120,763,254157,367,01286,168,338134,199,612118,287,630176,744,309
Dividend
Jun 18, 20261.082 /sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nanjing Vishee Medical Technology Co., Ltd. is a Chinese firm dedicated to creating and manufacturing a range of medical rehabilitation equipment. Their offerings encompass therapeutic solutions for pelvic floor and postpartum recovery, neurological conditions, and mental health challenges. Additionally, the company provides advanced bio-stimulation feedback instruments and magnetic stimulators. These technologies address diverse areas, including electrical and magnetic stimulation, electrophysiology, and other specialized technical fields. Nanjing Vishee distributes its products to hospitals and various medical and professional end-users primarily through its network of authorized dealers and sales channels. Established in 2001, the company's headquarters are located in Nanjing, China.
IPO date
Jul 21, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT